Once the patient is at a point where they're losing weight in a slow, consistent, healthy way, then we keep them on that dose until we've reached their goal weight, and then we slowly taper the medication off, Levites said
Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes: a 1-year randomized controlled trial
Most healthcare providers recommend a structured dose reduction over 8 to 16 weeks for the best long-term outcomes
Specifically, thyroid function should be rechecked 6-8 weeks after starting or titrating GLP-1 therapy, after significant weight loss, or after any levothyroxine dose change
That would put you at risk of undereating, which can result in nutrient deficiencies and muscle loss
2024;84:802-810.e6